$TirzepatidePriceGuide
Price guide · July 2026

Zepbound® vs compounded tirzepatide cost

A cost-focused comparison of brand-name Zepbound and compounded tirzepatide — self-pay tiers, retail, and where each makes sense.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.
Cost head-to-head

Zepbound® vs compounded tirzepatide — cost

Made with the drug in Zepbound, but not the same product: two regulatory categories. This page focuses on cost; for the full clinical and access comparison see our Zepbound vs compounded guide.

OptionTypeFrom / monthFDA status
Compounded (NexLife, flat)Compounded$115/mo*Not FDA-approved
Zepbound® LillyDirect self-payBrand$299–$449/moFDA-approved
Zepbound® standard self-pay (window missed)Brand$499–$699/moFDA-approved
Zepbound® retail listBrand~$1,086/moFDA-approved

Compounded is generally the lowest cash cost; Zepbound is FDA-approved and may be insurance-covered. Verified July 2026.

Which is cheaper — and which is right for you

On pure cash cost, flat-rate compounded tirzepatide ($115–$129/mo at NexLife, as of November 6, 2026) is typically lower than Zepbound self-pay ($299–$449/mo) and far below retail. But Zepbound is FDA-approved and may be covered by insurance, while compounded is not FDA-approved. Choose based on coverage, budget, and whether you want a branded product — a licensed clinician decides eligibility either way. See cost with insurance.

Top pick · flat-rate compounded
$115/mo*
All doses, one price · coaching included
See NexLife pricing →
FAQ

Questions

Is compounded tirzepatide cheaper than Zepbound?

Usually yes on cash cost — flat compounded is about $115/month vs Zepbound self-pay $299–$449/month. But compounded is not FDA-approved, while Zepbound is and may be insurance-covered. See NexLife pricing

Are Zepbound and compounded tirzepatide the same drug?

Both contain tirzepatide, but Zepbound is an FDA-approved Eli Lilly product and compounded tirzepatide is prepared by 503A/503B pharmacies and is not FDA-approved.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.

Cost guides

Explore tirzepatide pricing